Not Yet RecruitingNot Applicable

The Effect of a Multi-modal Program on Fear of Cancer Recurrence in Breast Cancer Patients

84 participantsStarted 2025-06-01

Plain-language summary

The goal of this clinical trial is to learn if MMP intervention can alleviate FCR , breast cancer symptoms and social support among breast cancer patients. he main questions it aims to answer are: * Null Hypotheses (H0): There is no significant difference in FCR, breast cancer symptoms, and social support between the MMP intervention group and the control group. * Alternative Hypotheses (H1): There are significant differences in FCR, breast cancer symptoms, and social support between the MMP intervention group and the control group Researchers will compare MMP to a routine care to see if MMP works to alleviate FCR, breast cancer symptoms and social support. Participants will: * Receive interventions once per chemotherapy cycle for 8 weeks. * The FCRI-SF, MSAS-SF-SC, and SSRS scales will be utilized to assess FCR levels, breast cancer symptoms and social support in both the experimental and control groups, with measurements conducted at baseline (T1), 8 weeks post-intervention (T2), and 12 weeks post-intervention (T3).

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis meets the criteria outlined in the Breast Cancer Diagnosis and Treatment Guidelines, with a pathological diagnosis of breast cancer and currently undergoing chemotherapy * Age ≥ 18 years * Clear consciousness and the ability to communicate independently * Aware of the diagnosis and has signed the informed consent form Exclusion Criteria: * Presence of mental illness or cognitive impairment * Hearing or speech impairmen * Distant metastasis of cance * Severe physical illness or other malignant tumors requiring treatment

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Fear of Cancer Recurrence Inventory-Short Form

Timeframe: baseline; 8 weeks post-intervention; 12 weeks post-intervention

The Social Support Rating Scale

Timeframe: baseline; 8 weeks post-intervention; 12 weeks post-intervention

The Chinese version of memorial symptom assessment scal

Timeframe: baseline; 8 weeks post-intervention; 12 weeks post-intervention

Trial details

NCT IDNCT06883877

SponsorLIU WEIMIN

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-30

Contact for this trial

Weimin Liu, Phd

86+15810515761 liuweimin3158@bjsjth.cn

View on ClinicalTrials.gov More Breast Cancer trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Fear of Cancer Recurrence Inventory-Short Form

Timeframe: baseline; 8 weeks post-intervention; 12 weeks post-intervention

The Social Support Rating Scale

Timeframe: baseline; 8 weeks post-intervention; 12 weeks post-intervention

The Chinese version of memorial symptom assessment scal

Timeframe: baseline; 8 weeks post-intervention; 12 weeks post-intervention